0001209191-22-059262.txt : 20221201 0001209191-22-059262.hdr.sgml : 20221201 20221201204737 ACCESSION NUMBER: 0001209191-22-059262 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221129 FILED AS OF DATE: 20221201 DATE AS OF CHANGE: 20221201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Jeff Marc CENTRAL INDEX KEY: 0001703061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 221440111 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS STREET 2: 55 CAMBRIDGE PARKWAY, STE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-29 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001703061 Goldberg Jeff Marc C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 1 1 0 0 President and CEO Employee Stock Option (right to buy) 1.22 2022-11-29 4 A 0 1884838 0.00 A 2032-11-28 Common Stock 1884838 1884838 D The stock option vests and becomes exercisable as to 1/4 of the total award on November 29, 2023, and an additional 1/48 of the award will vest monthly thereafter until the option is 100% vested on November 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ James Kastenmayer, by power of attorney 2022-12-01